No abstract available.
APACHE* ; Emergencies* ; Intraabdominal Infections*

No abstract available.
Breast Neoplasms* ; Breast*

No abstract available.
Glycerol* ; Hearing*

Purpose: The purpose of this study was to investigate the effect of a spouse’s aromatherapy hand massage on fatigue, stress, and a couple’s relationship in pregnant women. Methods: A nonequivalent control group pretest-posttest design was used. Pregnant women were selected as participants on prenatal education program of 2 health centers. For the experimental group, 28 pregnant women were selected from 1 health centers. Thirty-two pregnant women were assigned to a control group from another. Bergamot, lavender, and sandalwood oil were mixed at a ratio of 1:1:1 and diluted to 1% in a jojoba carrier oil. This oil was used for aromatherapy and had already been identified as not being hazardous to pregnant women. Participants received an aroma hand massage from their spouses 5 times a week for 4 weeks, a total of 20 times. Pre and post written survey were collected from both groups. The data were analyzed by χ2 test, independent t-test, paired t-test and analysis of covariance using IBM SPSS Statistics ver. 25.0 program.Result: There was a statistically significant difference in stress (F=17.39, p<0.001) and the couple’s relationship (F=18.87, p<0.001) between the experimental group and the control group. Fatigue was not significantly different between the 2 groups (F=2.61, p=0.112), but there was a difference pre and post the experimental group (t=-5.30, p<0.001). Conclusion These findings indicate that a spouse’s aroma hand massage is effective as a nursing intervention for pregnant women to relieve fatigue and stress, and improve the couple’s relationship.

No abstract available.

The complications of herpes zoster ophthalmicus vary greatly among different patients. The major portion of the complications fall under four types; (1) keratitis, (2) iridocyclitis, (3) muscular palsies, and (4) optic neuritis. We have experienced a case of herpes zoster ophthalmicus complicated by abducens palsy, sectorial paralysis of iris sphincter, iritis, and transient increase of intraocular pressure. The case was reviewed and the pathogenesis of the complications were discus sed.
Herpes Zoster Ophthalmicus* ; Herpes Zoster* ; Humans ; Intraocular Pressure ; Iridocyclitis ; Iris ; Iritis ; Keratitis ; Optic Neuritis ; Paralysis*

No abstract available.
Hospitals, General* ; Humans

PURPOSE: Patients with Kawasaki disease (KD) who remain febrile after first dose of intravenous immunoglobulin (IVIG) are usually treated with a second dose of IVIG. However, the optimal dosage of IVIG in the retreatment of KD is still controversial. We evaluated the impact of IVIG dose difference on the coronary artery lesion (CAL) in the retreatment of KD. METHODS: We performed a prospective study on 24 patients with KD requiring IVIG retreatment from January 2000 to December 2004. The patients were assigned to receive IVIG in the retreatment of KD either as a single infusion of 2 g/kg (A group, 12 patients) or 1 g/kg (B group, 24 patients). We compared the CAL of B group to that of A group for comparable risk of both groups. RESULTS: The incidence of CAL was significantly higher in the 5 of 24 (20.9%) patients with IVIG retreatment vs the 18 of 315 (5.8%) afebrile patients after first course of IVIG treatment (P=0.016). There were no significant differences in age, sex, and other clinical and laboratory findings known as risk factors of CAL between the two groups. Among 24 patients with IVIG retreatment, there were no significant difference in the incidence of CAL between the two groups(Group A, 3/12=25%, vs Group B, 2/12=16.7%) (P>0.05). CONCLUSION: Single 1 g/kg IVIG therapy is comparable outcome to single 2 g/kg IVIG therapy in the retreatment of KD, although the efficacy of this practice requires assessment with a randomized controlled prospective trial in more patients.
Coronary Vessels ; Humans ; Immunoglobulins* ; Immunoglobulins, Intravenous ; Incidence ; Mucocutaneous Lymph Node Syndrome* ; Prospective Studies ; Retreatment* ; Risk Factors

No abstract available.
Aflatoxin B1* ; Aflatoxins* ; Enzyme-Linked Immunosorbent Assay* ; Humans*

No abstract available.
Humans* ; Leukemia*